Zfp/ZNF423基因的表观遗传修饰调控小鼠脂肪生成定向并在人肥厚性肥胖中失调
研究探讨Zfp423基因的表观遗传调控及其在肥厚性肥胖脂肪生成受限中的作用。比较小鼠3T3-L1与NIH-3T3细胞及20名非糖尿病瘦者皮下前脂肪细胞,发现Zfp423表达随启动子DNA甲基化和核小体占据降低而升高,5-氮杂胞苷可逆转非脂肪生成表观遗传谱并诱导分化;人前脂肪细胞中ZNF423表观遗传调控受损与皮下脂肪细胞肥厚相关,且可被5-氮杂胞苷恢复。
要点
- 小鼠前脂肪细胞定向伴随Zfp423启动子DNA甲基化和核小体占据降低。
- 5-氮杂胞苷可升高Zfp423 mRNA、降低CpG位点甲基化并诱导NIH-3T3细胞脂肪分化。
- 人前脂肪细胞中ZNF423表观遗传调控受损与皮下脂肪细胞肥厚相关。
核心结论
- 表观遗传事件通过调控ZNF423影响前体细胞定向和分化为成熟脂肪细胞的能力,这些机制失调伴随人皮下脂肪组织肥厚。
研究设计与样本
- 使用小鼠3T3-L1(定向)和NIH-3T3(未定向)成纤维细胞,以及从20名脂肪细胞大小范围宽的非糖尿病瘦者皮下脂肪组织基质血管组分分离的人前脂肪细胞。
- mRNA水平用定量实时PCR检测,甲基化水平用亚硫酸氢盐测序分析,染色质结构用微球菌核酸酶保护试验分析,DNA甲基转移酶用5-氮杂胞苷化学抑制,脂肪细胞分化率用油红O染色评估。
主要发现
- 与未定向的NIH-3T3细胞相比,定向的3T3-L1细胞中Zfp423表达增加(p < 0.01),伴随启动子DNA甲基化降低(p < 0.001)和核小体占据降低(NUC1 p < 0.01;NUC2 p < 0.001)。
- 5-氮杂胞苷处理NIH-3T3细胞可升高Zfp423 mRNA水平(p < 0.01)、降低特定CpG位点DNA甲基化(p < 0.01)、降低核小体占据(NUC1、NUC2:p < 0.001)并诱导脂肪细胞分化(p < 0.05)。
- 这些表观遗传修饰也可响应前脂肪细胞微环境变化而启动,其中骨形态发生蛋白4(BMP4)起关键作用。
- 在人脂肪细胞前体细胞中,锌核因子(ZNF)423(小鼠Zfp423的人类同源物)的表观遗传调控受损与不适当的皮下脂肪细胞肥厚相关;与NIH-3T3细胞一样,5-氮杂胞苷暴露可恢复正常的ZNF423表观遗传谱。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Subcutaneous adipocyte hypertrophy is associated with insulin resistance and increased risk of type 2 diabetes, and predicts its future development independent of obesity. In humans, subcutaneous adipose tissue hypertrophy is a consequence of impaired adipocyte precursor cell recruitment into the adipogenic pathway rather than a lack of precursor cells. The zinc finger transcription factor known as zinc finger protein (ZFP) 423 has been identified as a major determinant of pre-adipocyte commitment and maintained white adipose cell function. Although its levels do not change during adipogenesis, ectopic expression of Zfp423 in non-adipogenic murine cells is sufficient to activate expression of the gene encoding peroxisome proliferator-activated receptor γ (Pparγ; also known as Pparg) and increase the adipogenic potential of these cells. We investigated whether the Zfp423 gene is under epigenetic regulation and whether this plays a role in the restricted adipogenesis associated with hypertrophic obesity. METHODS: Murine 3T3-L1 and NIH-3T3 cells were used as fibroblasts committed and uncommitted to the adipocyte lineage, respectively. Human pre-adipocytes were isolated from the stromal vascular fraction of subcutaneous adipose tissue of 20 lean non-diabetic individuals with a wide adipose cell size range. mRNA levels were measured by quantitative real-time PCR, while methylation levels were analysed by bisulphite sequencing. Chromatin structure was analysed by micrococcal nuclease protection assay, and DNA-methyltransferases were chemically inhibited by 5-azacytidine. Adipocyte differentiation rate was evaluated by Oil Red O staining. RESULTS: Comparison of uncommitted (NIH-3T3) and committed (3T3-L1) adipose precursor cells revealed that Zfp423 expression increased (p < 0.01) in parallel with the ability of the cells to differentiate into mature adipocytes owing to both decreased promoter DNA methylation (p < 0.001) and nucleosome occupancy (nucleosome [NUC] 1 p < 0.01; NUC2 p < 0.001) in the 3T3-L1 compared with NIH-3T3 cells. Interestingly, non-adipogenic epigenetic profiles can be reverted in NIH-3T3 cells as 5-azacytidine treatment increased Zfp423 mRNA levels (p < 0.01), reduced DNA methylation at a specific CpG site (p < 0.01), decreased nucleosome occupancy (NUC1, NUC2: p < 0.001) and induced adipocyte differentiation (p < 0.05). These epigenetic modifications can also be initiated in response to changes in the pre-adipose cell microenvironment, in which bone morphogenetic protein 4 (BMP4) plays a key role. We finally showed that, in human adipocyte precursor cells, impaired epigenetic regulation of zinc nuclear factor (ZNF)423 (the human orthologue of murine Zfp423) was associated with inappropriate subcutaneous adipose cell hypertrophy. As in NIH-3T3 cells, the normal ZNF423 epigenetic profile was rescued by 5-azacytidine exposure. CONCLUSIONS/INTERPRETATION: Our results show that epigenetic events regulate the ability of precursor cells to commit and differentiate into mature adipocytes by modulating ZNF423, and indicate that dysregulation of these mechanisms accompanies subcutaneous adipose tissue hypertrophy in humans.
引用
- Longo M, Raciti GA, Zatterale F, et al. Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity. Diabetologia. 2017. PMID: 29067487. doi:10.1007/s00125-017-4471-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。